Rupal Shah

Rupal Shah is a seasoned clinical development professional with over 20 years of experience in global clinical development, specializing in vaccines, infectious diseases, and rare diseases. Currently serving as the Director of Global Clinical Scientist at BioNTech SE, Rupal has previously held significant roles at Moderna and Pfizer, where they contributed to the development of notable vaccines, including Prevnar and mRNA COVID-19. Rupal holds a Bachelor of Science in Medical Microbiology and Bacteriology from V. P Science College and a Master of Science in Regulatory Affairs from Temple University. Their expertise encompasses designing and implementing clinical studies, preparing regulatory documents, and ensuring data integrity in clinical programs.